What We're Reading: Page 216
Industry reads hand-picked by our editors
Jun 24, 2019
Jun 21, 2019
-
Vanity Fair
"We Didn't Cause the Crisis": David Sackler Pleads His Case On The Opioid Epidemic
-
STAT
After a pharma lobbying blitz, Congress softens legislation on drug patents
-
The Wall Street Journal
Congress targets China's biotech ambitions
-
CNBC
CVS just laid out a big reason why health companies are worried about Amazon
Jun 20, 2019
Jun 19, 2019
Jun 18, 2019
-
Smithsonian.com
The woman who revealed the missing link between viruses and cancer
-
The New York Times
Bribes and backdoor deals help foreign firms sell to China's hospitals
-
Financial Times
Poor countries pay up to 30 times more for medicines
-
Bloomberg
Google and drugmaker Sanofi to join forces on data technologies
Jun 17, 2019
-
STAT
In science, is the line between industry and academia shifting?
-
The Washington Post
As price of insulin soars, Americans caravan to Canada for lifesaving medicine
-
The Wall Street Journal
China biotechs lure industry talent in the U.S.
-
Bloomberg
U.S. biotechs line up to list in Korea amid jump in share prices
Jun 14, 2019
-
FiercePharma
GSK may be reviving incentive pay for sales reps, but it's not returning to its old ways: executive
-
Boston Business Journal
Chicago biotech sues Third Rock, bluebird bio CEO over gene therapy license
-
Bloomberg
AstraZeneca markets an herbal-based remedy to expand in China
-
Los Angeles Times
12 million pills and 700 deaths: How a few pill mills helped fan the U.S. opioid inferno
Previous
